These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 26881932)
1. MT1-MMP Activation of TGF-β Signaling Enables Intercellular Activation of an Epithelial-mesenchymal Transition Program in Cancer. Nguyen HL; Kadam P; Helkin A; Cao K; Wu S; Samara GJ; Zhang Q; Zucker S; Cao J Curr Cancer Drug Targets; 2016; 16(7):618-30. PubMed ID: 26881932 [TBL] [Abstract][Full Text] [Related]
2. MT1-MMP Cooperates with TGF-β Receptor-Mediated Signaling to Trigger SNAIL and Induce Epithelial-to-Mesenchymal-like Transition in U87 Glioblastoma Cells. Djediai S; Gonzalez Suarez N; El Cheikh-Hussein L; Rodriguez Torres S; Gresseau L; Dhayne S; Joly-Lopez Z; Annabi B Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884812 [TBL] [Abstract][Full Text] [Related]
3. Membrane type 1-matrix metalloproteinase induces epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: Observations from clinical and in vitro analyses. Pang L; Li Q; Li S; He J; Cao W; Lan J; Sun B; Zou H; Wang C; Liu R; Wei C; Wei Y; Qi Y; Hu J; Liang W; Zhang WJ; Wan M; Li F Sci Rep; 2016 Feb; 6():22179. PubMed ID: 26916665 [TBL] [Abstract][Full Text] [Related]
4. Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells. Yang CC; Zhu LF; Xu XH; Ning TY; Ye JH; Liu LK BMC Cancer; 2013 Apr; 13():171. PubMed ID: 23548172 [TBL] [Abstract][Full Text] [Related]
5. The metastasis suppressor CD82/KAI1 represses the TGF-β Lee MS; Lee J; Kim YM; Lee H Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375 [TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta induces CD44 cleavage that promotes migration of MDA-MB-435s cells through the up-regulation of membrane type 1-matrix metalloproteinase. Kuo YC; Su CH; Liu CY; Chen TH; Chen CP; Wang HS Int J Cancer; 2009 Jun; 124(11):2568-76. PubMed ID: 19243022 [TBL] [Abstract][Full Text] [Related]
7. Critical roles of Wnt5a-Ror2 signaling in aggressiveness of tongue squamous cell carcinoma and production of matrix metalloproteinase-2 via ΔNp63β-mediated epithelial-mesenchymal transition. Sakamoto T; Kawano S; Matsubara R; Goto Y; Jinno T; Maruse Y; Kaneko N; Hashiguchi Y; Hattori T; Tanaka S; Kitamura R; Kiyoshima T; Nakamura S Oral Oncol; 2017 Jun; 69():15-25. PubMed ID: 28559016 [TBL] [Abstract][Full Text] [Related]
8. Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells. Cepeda MA; Pelling JJ; Evered CL; Williams KC; Freedman Z; Stan I; Willson JA; Leong HS; Damjanovski S Mol Cancer; 2016 Oct; 15(1):65. PubMed ID: 27756325 [TBL] [Abstract][Full Text] [Related]
9. Decreased MT1-MMP in gastric cancer suppressed cell migration and invasion via regulating MMPs and EMT. Li W; Li S; Deng L; Yang S; Li M; Long S; Chen S; Lin F; Xiao L Tumour Biol; 2015 Sep; 36(9):6883-9. PubMed ID: 25851348 [TBL] [Abstract][Full Text] [Related]
10. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition. Prasad CP; Chaurasiya SK; Guilmain W; Andersson T J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766 [TBL] [Abstract][Full Text] [Related]
11. Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1. Ota I; Li XY; Hu Y; Weiss SJ Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20318-23. PubMed ID: 19915148 [TBL] [Abstract][Full Text] [Related]
13. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling. Fisher KE; Pop A; Koh W; Anthis NJ; Saunders WB; Davis GE Mol Cancer; 2006 Dec; 5():69. PubMed ID: 17156449 [TBL] [Abstract][Full Text] [Related]
14. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway. Kim YS; Choi KC; Hwang KA Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941 [TBL] [Abstract][Full Text] [Related]
15. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer. Juang YL; Jeng YM; Chen CL; Lien HC Mol Carcinog; 2016 Dec; 55(12):2247-2259. PubMed ID: 26824226 [TBL] [Abstract][Full Text] [Related]
16. The tetraspanin CD81 protein increases melanoma cell motility by up-regulating metalloproteinase MT1-MMP expression through the pro-oncogenic Akt-dependent Sp1 activation signaling pathways. Hong IK; Byun HJ; Lee J; Jin YJ; Wang SJ; Jeoung DI; Kim YM; Lee H J Biol Chem; 2014 May; 289(22):15691-704. PubMed ID: 24733393 [TBL] [Abstract][Full Text] [Related]
17. SCUBE3 is an endogenous TGF-β receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer. Wu YY; Peck K; Chang YL; Pan SH; Cheng YF; Lin JC; Yang RB; Hong TM; Yang PC Oncogene; 2011 Aug; 30(34):3682-93. PubMed ID: 21441952 [TBL] [Abstract][Full Text] [Related]
18. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis. Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420 [TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer cells respond to type I collagen by inducing snail expression to promote membrane type 1 matrix metalloproteinase-dependent collagen invasion. Shields MA; Dangi-Garimella S; Krantz SB; Bentrem DJ; Munshi HG J Biol Chem; 2011 Mar; 286(12):10495-504. PubMed ID: 21288898 [TBL] [Abstract][Full Text] [Related]
20. Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells. Kim YJ; Jeon Y; Kim T; Lim WC; Ham J; Park YN; Kim TJ; Ko H Bioorg Med Chem Lett; 2017 Feb; 27(4):1081-1088. PubMed ID: 28110870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]